ProSciento is now enrolling adults for a research study testing a new investigational oral medication (called MK-1403) that may help reduce inflammation in people with Type 2 Diabetes. The study is looking at how safe the medication is and how it affects certain markers in the blood linked to inflammation.

Screening and all study visits will be at our San Diego area research clinic. Transportation can be arranged by and paid for by ProSciento. You do not need to live in San Diego, CA to participate. We encourage those that reside in neighboring cities to also participate.

You do not need health insurance to participate. All study tests and examinations will be at no cost to you.

Start the process today! During your 1-on-1 call, we’ll get more health information from you. We will use this information to find out if you are eligible for this study or any other paid and actively enrolling studies at our research center.

ProSciento is now enrolling adults for a paid research study being conducted to learn more about how well the study medication, taldefgrobep, works and how safe it is for people who are overweight or living with obesity. The main goal is to see how taldefgrobep compares to a placebo (a substance with no active medication) in helping reduce total body weight over a 24-week period.

The study will also look at whether taldefgrobep helps reduce body fat and it’s impact on lean body mass, which includes muscle and other non-fat tissues. In addition, researchers will closely monitor how safe the medication is and how well participants tolerate it throughout the study.

Screening and all study visits will be at our San Diego area research clinic. Transportation can be arranged by and paid for by ProSciento.  You do not need health insurance to participate. All study tests and examinations will be at no cost to you.

Start the process today! During your 1-on-1 call, we’ll get more health information from you. We will use this information to find out if you are eligible for this study or any other paid and actively enrolling studies at our research center.

ProSciento is partnering with Medtronic to conduct a study to collect data on the performance of glucose sensors with both commercially available devices and investigational devices used independently or in combination with each other. 

Screening and all study visits will be at our San Diego area research clinic. Transportation can be arranged by and paid for by ProSciento. You do not need to live in San Diego, CA to participate. We encourage those that reside in neighboring cities to also participate.

You do not need health insurance to participate. All study tests and examinations will be at no cost to you.

Start the process today! During your 1-on-1 call, we’ll get more health information from you. We will use this information to find out if you are eligible for this study or any other paid and actively enrolling studies at our research center.

ProSciento is now enrolling for a study being conducted in healthy volunteers to evaluate the effect of other medications on the investigational drug RGT001-075 (GLP-1 receptor agonist). The primary goal is to see how clarithromycin (antibiotic) (a strong CYP3A inhibitor) and carbamazepine (anticonvulsant) (a strong CYP3A inducer) change the way RGT001-075 is absorbed, processed, and eliminated by the body. A secondary goal is to compare the safety and tolerability of RGT001-075 when taken alone versus when taken with clarithromycin or carbamazepine.

Screening and all study visits will be at our San Diego area research clinic. Transportation can be arranged by and paid for by ProSciento. You do not need to live in San Diego, CA to participate. We encourage those that reside in neighboring cities to also participate.

You do not need health insurance to participate. All study tests and examinations will be at no cost to you.

Start the process today! During your 1-on-1 call, we’ll get more health information from you. We will use this information to find out if you are eligible for this study or any other paid and actively enrolling studies at our research center.

ProSciento is now enrolling adults for a paid research study testing an investigational oral study medication (MK-2828) that may possibly help improve heart and kidney diseases in people living with type 2 diabetes.

If you are enrolled in the study, your participation will be up to 11 weeks, including the screening period, outpatient visits, at-home dosing, and follow-up calls/visit.

Screening and all study visits will be at our San Diego area research clinic. Transportation can be arranged by and paid for by ProSciento. You do not need to live in San Diego, CA to participate. We encourage those that reside in neighboring cities to also participate.

You do not need health insurance to participate. All study tests and examinations will be at no cost to you.

Start the process today! During your 1-on-1 call, we’ll get more health information from you. We will use this information to find out if you are eligible for this study or any other paid and actively enrolling studies at our research center.

ProSciento is currently conducting a clinical research study evaluating an investigational insulin product, I005R U-500, developed by Amphastar Pharmaceuticals. The main goal of this study is to compare I005R U-500 to the FDA-approved insulin HUMULIN® R U-500 to assess how similarly they behave in the body. Both study medications are manufactured insulin formulations designed to mimic human insulin and are used to help manage blood sugar levels in people with diabetes.

Screening and all study visits will be at our San Diego area research clinic. Transportation can be arranged by and paid for by ProSciento. You do not need to live in San Diego, CA to participate. We encourage those that reside in neighboring cities to also participate.

You do not need health insurance to participate. All study tests and examinations will be at no cost to you.

Start the process today! During your 1-on-1 call, we’ll get more health information from you. We will use this information to find out if you are eligible for this study or any other paid and actively enrolling studies at our research center.

ProSciento is now enrolling participants in a research study being done to evaluate the safety and tolerability of a new medication in development for the treatment of risk factors that can lead to cardiovascular disease. You do not need to have cardiovascular disease to participate. The main goal of the study is to measure changes in triglycerides and cholesterol (remnant cholesterol) after eating a meal.

Screening and all study visits will be at our San Diego area research clinic. Transportation can be arranged by and paid for by ProSciento. You do not need to live in San Diego, CA to participate. We encourage those that reside in neighboring cities to also participate.

You do not need health insurance to participate. All study tests and examinations will be at no cost to you.

Start the process today! During your 1-on-1 call, we’ll get more health information from you. We will use this information to find out if you are eligible for this study or any other paid and actively enrolling studies at our research center.

ProSciento is now enrolling participants in a research study evaluating a new investigational treatment that may help reduce body weight and improve blood glucose levels in individuals with type 2 diabetes. This study tests how the body responds to the treatment using a specialized procedure called a glucose clamp.

Screening and all study visits will be at our San Diego area research clinic. Transportation can be arranged by and paid for by ProSciento. You do not need to live in San Diego, CA to participate. We encourage those that reside in neighboring cities to also participate.

You do not need health insurance to participate. All study tests and examinations will be at no cost to you.

Start the process today! During your 1-on-1 call, we’ll get more health information from you. We will use this information to find out if you are eligible for this study or any other paid and actively enrolling studies at our research center.

ProSciento is now enrolling participants in a research study being done to evaluate the safety and tolerability of a new medication in development for the treatment of risk factors that can lead to cardiovascular disease. You do not need to have cardiovascular disease to participate. The main goal of the study is to measure changes in triglycerides and cholesterol (remnant cholesterol) after eating a meal.

Screening and all study visits will be at our San Diego area research clinic. Transportation can be arranged by and paid for by ProSciento. You do not need to live in San Diego, CA to participate. We encourage those that reside in neighboring cities to also participate.

You do not need health insurance to participate. All study tests and examinations will be at no cost to you.

Start the process today! During your 1-on-1 call, we’ll get more health information from you. We will use this information to find out if you are eligible for this study or any other paid and actively enrolling studies at our research center.

ProSciento is now enrolling participants in a research study being done to evaluate the safety and tolerability of a new medication in development for the treatment of risk factors that can lead to cardiovascular disease. You do not need to have cardiovascular disease to participate. The main goal of the study is to measure changes in triglycerides and cholesterol (remnant cholesterol) after eating a meal.

Screening and all study visits will be at our San Diego area research clinic. Transportation can be arranged by and paid for by ProSciento. You do not need to live in San Diego, CA to participate. We encourage those that reside in neighboring cities to also participate.

You do not need health insurance to participate. All study tests and examinations will be at no cost to you.

Start the process today! During your 1-on-1 call, we’ll get more health information from you. We will use this information to find out if you are eligible for this study or any other paid and actively enrolling studies at our research center.